Angiotensin-(1-9) Attenuates Cardiac Fibrosis in the Stroke-Prone Spontaneously Hypertensive Rat via the Angiotensin Type 2 Receptor
- 1 February 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 59 (2) , 300-307
Abstract
The renin-angiotensin system regulates cardiovascular physiology via angiotensin II engaging the angiotensin type 1 or type 2 receptors. Classic actions are type 1 receptor mediated, whereas the type 2 receptor may counteract type 1 receptor activity. Angiotensin-converting enzyme 2 metabolizes angiotensin II to angiotensin-(1-7) and angiotensin I to angiotensin-(1-9). Angiotensin-(1-7) antagonizes angiotensin II actions via the receptor Mas. Angiotensin-(1-9) was shown recently to block cardiomyocyte hypertrophy via the angiotensin type 2 receptor. Here, we investigated in vivo effects of angiotensin-(1-9) via the angiotensin type 2 receptor. Angiotensin-(1-9) (100 ng/kg per minute) with or without the angiotensin type 2 receptor antagonist PD123 319 (100 ng/kg per minute) or PD123 319 alone was infused via osmotic minipump for 4 weeks into stroke-prone spontaneously hypertensive rats. We measured blood pressure by radiotelemetry and cardiac structure and function by echocardiography. Angiotensin-(1-9) did not affect blood pressure or left ventricular mass index but reduced cardiac fibrosis by 50% (PN-nitro-l-arginine methyl ester treatment, an effect abolished by PD123 319 coinfusion (area under the curve: angiotensin-(1-9) N-nitro-l-arginine methyl ester=98.9±11.8%; control+N-nitro-l-arginine methyl ester=74.0±10.4%; P<0.01), suggesting that angiotensin-(1-9) improved basal NO bioavailability in an angiotensin type 2 receptor–sensitive manner. In summary, angiotensin-(1-9) reduced cardiac fibrosis and altered aortic contraction via the angiotensin type 2 receptor supporting a direct role for angiotensin-(1-9) in the renin-angiotensin system.Keywords
This publication has 39 references indexed in Scilit:
- Angiotensin1‐9 antagonises pro‐hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptorThe Journal of Physiology, 2011
- Stromal regulation of vessel stability by MMP14 and TGFβDisease Models & Mechanisms, 2010
- Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosisAmerican Journal of Physiology-Renal Physiology, 2010
- Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac HypertrophyHypertension, 2009
- Role of protein kinase C-δ in angiotensin II induced cardiac fibrosisBiochemical and Biophysical Research Communications, 2009
- Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunctionJournal of Experimental Medicine, 2007
- Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent PathwaysHypertension, 2007
- Angiotensin II Type 2 Receptor–Bradykinin B 2 Receptor Functional HeterodimerizationHypertension, 2006
- Prevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene TransferHypertension, 2004
- Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986